Anti-Human CA9 Monoclonal Antibody (1A630)

Anti-Human CA9 Monoclonal Antibody (1A630)

Top-of-the-line Anti-Human CA9 Monoclonal Antibody (1A630) – the ultimate solution for your biotech research needs.

This highly specific and potent antibody targets Carbonic Anhydrase 9 (CA9), a protein that plays a crucial role in tumor growth and progression. By binding to CA9, this antibody effectively inhibits its function, making it a valuable tool for studying the role of CA9 in cancer biology.

With its exceptional specificity and affinity, our Anti-Human CA9 Monoclonal Antibody (1A630) is ideal for a wide range of applications. It can be used for Western blotting, immunohistochemistry, and flow cytometry, providing reliable and reproducible results every time.

But that’s not all – our antibody has also been extensively tested in various experimental models, including human tumor xenografts and patient samples. This makes it a highly reliable and well-validated tool for studying CA9 expression and function in different cancer types.

In addition to its research applications, our Anti-Human CA9 Monoclonal Antibody (1A630) has also shown promising results in clinical studies. It has been used in diagnostic tests for detecting CA9 expression in cancer patients, as well as in targeted therapies for inhibiting CA9 activity and suppressing tumor growth.

So why choose our Anti-Human CA9 Monoclonal Antibody (1A630)? Not only does it offer exceptional specificity and sensitivity, but it also has a proven track record in both research and clinical settings. With this antibody, you can confidently delve into the complex world of CA9 biology and make groundbreaking discoveries.

Don’t wait any longer – order our Anti-Human CA9 Monoclonal Antibody (1A630) now and take your biotech research to the next level. Trust us, you won’t be disappointed.